A Life Sciences Consulting & Venture Capital Firm
Kineticos is a life sciences consulting firm that represents centers of excellence in cell & gene therapy, oncology, neuroscience and rare diseases combined with a vast depth of expertise in driving strategy and growth for companies in these areas.
Kineticos Ventures’ portfolio of investments is made up of biotechs striving to disrupt how drugs are developed, diseases are diagnosed, and patients are treated. The Kineticos Ventures fund focuses on significant, unmet medical needs in oncology, neurosciences, and rare diseases.
We’re considering expanding into a new market. Is it a good idea?
Market Opportunity & Competitive Analysis
I need help refining my commercialization model for a new market.
Go-To-Market Strategy & Business Cases
Kineticos brought a methodical approach, experienced resources, and industry contacts to help advance our projects to a swift conclusion.
Bob Jones, CEO, Acura Pharmaceuticals
The insights Kineticos provided on a strategic portfolio assessment were highly actionable, and we have implemented a new strategy based on the findings – a hugely successful project!
Oliver Schacht, CEO, OpGen
Our strategic work with Kineticos provided us immense fire power to reach out to biopharmaceutical companies interested in partnering our gene, CRISPR and cell therapy programs.
Oscar Segurado, CMO, ASC Therapeutics
We engaged with Kineticos to research a new market for a potential investment. The insights were immediately actionable, the team was highly responsive, and communication was excellent.
David Anderson, General Partner, Ampersand
On numerous occasions the Kineticos team has promptly and diligently conducted market research through KOLs and data driven insights.”
Mark Bamforth, CEO, Arranta Bio
Is this a good strategic investment given my firm’s existing life sciences investment portfolio?
May 17, 2022
May 17, 2022 Kineticos Life Sciences Announces Tom Pitler as President and Chief Operating Officer
December 2, 2021
December 2, 2021 Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market
April 28, 2021
April 28, 2021 Kineticos Announces Frank Lis as President and CEO of Kineticos Ventures
If you are seeking help, more information, or would like to discuss your next initiative with our experts, contact us today.
Kineticos Life Sciences
9131 Anson Way
Raleigh, NC 27615